126 related articles for article (PubMed ID: 8815686)
1. Therapy for chronic hepatitis B infection.
Terrault NA; Wright TL
Adv Exp Med Biol; 1996; 394():189-205. PubMed ID: 8815686
[TBL] [Abstract][Full Text] [Related]
2. Therapy of viral hepatitis.
Hoofnagle JH
Digestion; 1998 Aug; 59(5):563-78. PubMed ID: 9705540
[TBL] [Abstract][Full Text] [Related]
3. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B.
Yuen MF; Lai CL
Lancet Infect Dis; 2001 Nov; 1(4):232-41. PubMed ID: 11871510
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis B infection using interferon.
Guan R
Med J Malaysia; 2005 Jul; 60 Suppl B():28-33. PubMed ID: 16108170
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus: old, new and future approaches to antiviral treatment.
Karayiannis P
J Antimicrob Chemother; 2003 Apr; 51(4):761-85. PubMed ID: 12654750
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum and histology of patients with chronic hepatitis B after interferon alpha-2b treatment.
Han HL; Lang ZW
World J Gastroenterol; 2003 Jan; 9(1):117-21. PubMed ID: 12508364
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
[TBL] [Abstract][Full Text] [Related]
9. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
[TBL] [Abstract][Full Text] [Related]
11. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
;
J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
13. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
15. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
Wu D; Ning Q
J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
[TBL] [Abstract][Full Text] [Related]
16. New options in the treatment of chronic hepatitis.
Soemohardjo S
Adv Exp Med Biol; 2003; 531():191-8. PubMed ID: 12916791
[TBL] [Abstract][Full Text] [Related]
17. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy: hepatitis B.
Jacyna MR; Thomas HC
Br Med Bull; 1990 Apr; 46(2):368-82. PubMed ID: 1696158
[TBL] [Abstract][Full Text] [Related]
20. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
